We hypothesise that baseline differences in CD35 levels between children at the time of infection might influence their susceptibility to SMA; studies have assessed expression of complement regulatory proteins at SMA diagnosis and after treatment11,13, but not at baseline. This evidence concerns the gene CR1 and infection.